Showing 321 - 340 results of 1,871 for search '(( ct ((values decrease) OR (largest decrease)) ) OR ( a ((teer decrease) OR (linear decrease)) ))', query time: 0.58s Refine Results
  1. 321

    Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

    Published 2025
    “…In this study, a linear poly(<i>N</i>-(2-hydroxypropyl)methacrylamide) (LP(HPMA))-coated capillary was prepared by using the surface-confined aqueous reversible addition–fragmentation chain transfer polymerization method. …”
  2. 322

    Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

    Published 2025
    “…In this study, a linear poly(<i>N</i>-(2-hydroxypropyl)methacrylamide) (LP(HPMA))-coated capillary was prepared by using the surface-confined aqueous reversible addition–fragmentation chain transfer polymerization method. …”
  3. 323

    Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

    Published 2025
    “…In this study, a linear poly(<i>N</i>-(2-hydroxypropyl)methacrylamide) (LP(HPMA))-coated capillary was prepared by using the surface-confined aqueous reversible addition–fragmentation chain transfer polymerization method. …”
  4. 324

    Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

    Published 2025
    “…In this study, a linear poly(<i>N</i>-(2-hydroxypropyl)methacrylamide) (LP(HPMA))-coated capillary was prepared by using the surface-confined aqueous reversible addition–fragmentation chain transfer polymerization method. …”
  5. 325

    Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

    Published 2025
    “…In this study, a linear poly(<i>N</i>-(2-hydroxypropyl)methacrylamide) (LP(HPMA))-coated capillary was prepared by using the surface-confined aqueous reversible addition–fragmentation chain transfer polymerization method. …”
  6. 326

    Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

    Published 2025
    “…In this study, a linear poly(<i>N</i>-(2-hydroxypropyl)methacrylamide) (LP(HPMA))-coated capillary was prepared by using the surface-confined aqueous reversible addition–fragmentation chain transfer polymerization method. …”
  7. 327

    Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

    Published 2025
    “…In this study, a linear poly(<i>N</i>-(2-hydroxypropyl)methacrylamide) (LP(HPMA))-coated capillary was prepared by using the surface-confined aqueous reversible addition–fragmentation chain transfer polymerization method. …”
  8. 328

    Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

    Published 2025
    “…In this study, a linear poly(<i>N</i>-(2-hydroxypropyl)methacrylamide) (LP(HPMA))-coated capillary was prepared by using the surface-confined aqueous reversible addition–fragmentation chain transfer polymerization method. …”
  9. 329
  10. 330
  11. 331
  12. 332
  13. 333
  14. 334

    Subgroup analysis of AIP and depression. by Siyi Deng (12887198)

    Published 2025
    “…</p><p>Results</p><p>In comparison to quartile 1, Multivariate logistic regression revealed that AIP in quartiles 2–4 yielded odd ratios (ORs) (95% confidence interval, 95% CI) of premenopausal women of 1.14 (0.87, 1.50), 1.06 (0.79, 1.42), and 1.49 (1.11, 2.00), and postmenopausal women of 0.88 (0.64, 1.22), 1.03 (0.76, 1.41) and 1.40 (1.04, 1.89), respectively. RCS showed a linear correlation between AIP and depression in premenopausal women and a nonlinear correlation between AIP and depression in postmenopausal women. …”
  15. 335
  16. 336

    Univariate analyses. by Zachary E. M. Giovannini-Green (22008277)

    Published 2025
    “…ED utilization by individuals with psychotic disorders increased during the first year of the COVID-19 pandemic, while ED use by most Canadians decreased. This study identified the demographics of Canadians who require extra support during a health crisis. …”
  17. 337

    Overview of individuals in the study. by Zachary E. M. Giovannini-Green (22008277)

    Published 2025
    “…ED utilization by individuals with psychotic disorders increased during the first year of the COVID-19 pandemic, while ED use by most Canadians decreased. This study identified the demographics of Canadians who require extra support during a health crisis. …”
  18. 338

    Multivariate analyses. by Zachary E. M. Giovannini-Green (22008277)

    Published 2025
    “…ED utilization by individuals with psychotic disorders increased during the first year of the COVID-19 pandemic, while ED use by most Canadians decreased. This study identified the demographics of Canadians who require extra support during a health crisis. …”
  19. 339
  20. 340